div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imageimg data-url=drug-majors-cipla-ranbaxy-lab-hetero-drugs-natco-pharma-and-others-on-an-appealhtmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: · drug majors Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others on an appeal filed by Swiss firm Novartis challenging the denial of Patent for Glivec its blood cancer loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentssitereader030viewer20220409185e93289267390c7c8267af48html5thumbnails1jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imageimg data-url=drug-majors-cipla-ranbaxy-lab-hetero-drugs-natco-pharma-and-others-on-an-appealhtmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: · drug majors Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others on an appeal filed by Swiss firm Novartis challenging the denial of Patent for Glivec its blood cancer loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentssitereader030viewer20220409185e93289267390c7c8267af48html5thumbnails2jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imageimg data-url=drug-majors-cipla-ranbaxy-lab-hetero-drugs-natco-pharma-and-others-on-an-appealhtmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: · drug majors Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others on an appeal filed by Swiss firm Novartis challenging the denial of Patent for Glivec its blood cancer loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentssitereader030viewer20220409185e93289267390c7c8267af48html5thumbnails3jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imageimg data-url=drug-majors-cipla-ranbaxy-lab-hetero-drugs-natco-pharma-and-others-on-an-appealhtmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: · drug majors Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others on an appeal filed by Swiss firm Novartis challenging the denial of Patent for Glivec its blood cancer loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentssitereader030viewer20220409185e93289267390c7c8267af48html5thumbnails4jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imageimg data-url=drug-majors-cipla-ranbaxy-lab-hetero-drugs-natco-pharma-and-others-on-an-appealhtmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: · drug majors Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others on an appeal filed by Swiss firm Novartis challenging the denial of Patent for Glivec its blood cancer loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentssitereader030viewer20220409185e93289267390c7c8267af48html5thumbnails5jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imageimg data-url=drug-majors-cipla-ranbaxy-lab-hetero-drugs-natco-pharma-and-others-on-an-appealhtmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: · drug majors Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others on an appeal filed by Swiss firm Novartis challenging the denial of Patent for Glivec its blood cancer loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentssitereader030viewer20220409185e93289267390c7c8267af48html5thumbnails6jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=7Page 7button div class=ts-imageimg data-url=drug-majors-cipla-ranbaxy-lab-hetero-drugs-natco-pharma-and-others-on-an-appealhtmlpage=7 data-page=7 class=ts-thumb lazyload alt=Page 7: · drug majors Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others on an appeal filed by Swiss firm Novartis challenging the denial of Patent for Glivec its blood cancer loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentssitereader030viewer20220409185e93289267390c7c8267af48html5thumbnails7jpg width=140 height=200 divdivdiv class=ts-pagebutton class=gotoPage data-page=8Page 8button div class=ts-imageimg data-url=drug-majors-cipla-ranbaxy-lab-hetero-drugs-natco-pharma-and-others-on-an-appealhtmlpage=8 data-page=8 class=ts-thumb lazyload alt=Page 8: · drug majors Cipla Ranbaxy Lab Hetero Drugs Natco Pharma and others on an appeal filed by Swiss firm Novartis challenging the denial of Patent for Glivec its blood cancer loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader030vdocumentssitereader030viewer20220409185e93289267390c7c8267af48html5thumbnails8jpg width=140 height=200 divdiv
